Semiconductor nanocrystal-aptamer bioconjugate probes for specific prostate carcinoma cell targeting

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 5705, Issue , 2005, Pages 159-165

  Shieh, Felice ^a   Lavery, Laura ^b   Chu, Chitai Ted ^b   Richards Kortum, Rebecca ^a   Ellington, Andrew D ^b   Korgel, Brian A ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Aptamer; Bioconjugates; Cell labeling; Prostate cell carcinoma; PSMA; Semiconductor nanocrystals

Indexed keywords

APTAMER; BIOCONJUGATES; CELL LABELING; PROSTATE CELL CARCINOMA; PROSTATE-SPECIFIC MAMBRANES ANTIGENS (PSMA); SEMICONDUCTOR NANOCRYSTALS;

ANTIGENS; BIOLOGICAL ORGANS; CELLS; DNA; FLUORESCENCE; HYDROGEN BONDS; MEDICAL IMAGING; PROTEINS; RNA; TUMORS;

NANOSTRUCTURED MATERIALS;

EID: 23244434816     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.597249     Document Type: Conference Paper

References (45)

1. Society, A. C. "Cancer Facts and Figures 2004," American Cancer Society: Cancer Statistics for 2004, 2004.
2. Ward, A. M., Catto, J. W. F., and Hamdy, F. C. "Prostate specific antigen: biology, biochemistry and available commercial assays," Annals of Clinical Biochemistry 38 (2001): 633-651.
3. Greenberg, D. L., Mize, G. J., and Takayama, T. K. "Protease- Activated Receptor Mediated RhoA Signaling and Cytoskeletal Reorganization in LNCaP Cells," Biochemistry 42 (2003): 702-709.
4. Murphy, G. P. "Report on the American Urologic Association/American Cancer Society scientific seminar on the detection and treatment of early-stage prostate cancer," CA: a cancer journal for clinicians 44 (1994): 91-5.
5. Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., and Bander, N. H. "Constitutive and antibody-induced internalization of prostate-specific membrane antigen," Cancer Research 58 (1998): 4055-4060.
6. Lopes, A. D., Davis, W. L., Rosenstraus, M. J., Uveges, A. J., and Gilman, S. C. "Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5," Cancer Research 50 (1990): 6423-9.
7. Wright, G. L., Jr., Haley, C., Beckett, M.L., Schellhammer, P.F. "Expression of the prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.," Urologic Oncology 1 (1995): 18-28.
8. Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D., and Cordon-Cardo, C. "Prostate-specific membrane antigen expression in normal and malignant human tissues," Clinical cancer research : an official journal of the American Association for Cancer Research 3 (1997): 81-5.
9. Chang, S. S., and Heston, W. D. W. "The clinical role of prostate-specific membrane antigen (PSMA)," Urologic Oncology 7 (2002): 7-12.
10. Su, S. L., Huang, I.-P., Fair, W. R., Powell, C. T., and Heston, W. D. W. "Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression," Cancer Research 55 (1995): 1441-3.
11. Chang, S. S., Reuter, V. E., Heston, W. D. W., Bander, N. H., Grauer, L. S., and Gaudin, P. B. "Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature," Cancer Research 59 (1999): 3192-3198.
12. Brody, E. N., and Gold, L. "Aptamers as therapeutic and diagnostic agents," Reviews in Molecular Biotechnology 74 (2000): 5-13.
13. Connell, G. J., Illangesekare, M., and Yarus, M. "Three small ribooligonucleotides with specific arginine sites," Biochemistry 32 (1993): 5497-502.
14. Tuerk, C., and Gold, L. "Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase," Science (Washington, DC, United States) 249 (1990): 505-10.
15. Ellington, A. D., and Szostak, J. W. "In vitro selection of RNA molecules that bind specific ligands," Nature (London, United Kingdom) 346 (1990): 818-22.
16. Bullock, T. L., Sherlin, L. D., and Perona, J. J. "Tertiary core rearrangements in a tight binding transfer RNA aptamer," Nature Structural Biology 7 (2000): 497-504.
17. Cowan, J. A., Ohyama, T., Wang, D., and Natarajan, K. "Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions," Nucleic Acids Research 28 (2000): 2935-2942.
18. Babendure, J. R., Adams, S. R., and Tsien, R. Y. "Aptamers switch on fluorescence of triphenylmethane dyes," Journal of the American Chemical Society 125 (2003): 14716-14717.
19. Bertrand, E., Chartrand, P., Schaefer, M., Shenoy, S. M., Singer, R. H., and Long, R. M. "Localization of ASH1 mRNA particles in living yeast," Molecular cell 2 (1998): 437-45.
20. Irie, K., Tadauchi, T., Takizawa, P. A., Vale, R. D., Matsumoto, K., and Herskowitz, I. "The Khdl protein, which has three KH RNA-binding motifs, is required for proper localization of ASH1 mRNA in yeast," EMBO Journal 21 (2002): 1158-1167.
21. Long, R. M., Gu, W., Lorimer, E., Singer, R. H., and Chartrand, P. "She2p is a novel RNA-binding protein that recruits the Myo4p-She3p complex to ASH1 mRNA," EMBO journal 19 (2002): 6592-601.
22. Stanlis, K. K. H., and McIntosh, J. R. "Single-strand DNA aptamers as probes for protein localization in cells," Journal of Histochemistry and Cytochemistry 51 (2003): 797-808.
23. Hermanson, G. T. "Chapter 8," Bioconjugation Techniques. London, UK: Academic Press, 1996.
24. Mitchell, P. "Turning the spotlight on cellular imaging," Nature Biotechnology 19 (2001): 1013-1017.
25. Mattoussi, H., Mauro, J. M., Goldman, E. R., Anderson, G. P., Sundar, V. C., Mikulec, F. V., and Bawendi, M. G. "Self-Assembly of CdSe-ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein," Journal of the American Chemical Society 122 (2000): 12142-12150.
26. Bruchez, M., Jr., Moronne, M., Gin, P., Weiss, S., and Alivisatos, A. P. "Semiconductor nanocrystals as fluorescent biological labels," Science (Washington, D. C.) 281 (1998): 2013-2016.
27. Lupold, S. E., Hicke, B. J., Lin, Y., and Coffey, D. S. "Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen," Cancer Research 62 (2002): 4029-4033.
28. Gaponik, N., Talapin, D. V., Rogach, A. L., Hoppe, K., Shevchenko, E. V., Kornowski, A., Eychmueller, A., and Weller, H. "Thiol-Capping of CdTe Nanocrystals: An Alternative to Organometallic Synthetic Routes," Journal of Physical Chemistry B 106 (2002): 7177-7185.
29. Allport, J. R., and Weissleder, R. "In vivo imaging of gene and cell therapies," Experimental hematology 29 (2001): 1237-46.
30. Han, M., Gao, X., Su, J. Z., and Nie, S. "Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules," Nature Biotechnology 19 (2001): 631-635.
31. Peng, Z. A., and Peng, X. "Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor," J. Am. Chem. Soc. 123 (2001): 183-184.
32. Wuister, S. F., Swart, I., van Driel, F., Hickey, S. G., and Donega, C. d. M. "Highly Luminescent Water-Soluble CdTe Quantum Dots," Nano Letters 3 (2003): 503-507.
33. Derfus, A. M., Chan, W. C. W., and Bhatia, S. N. "Probing the Cytotoxicity of Semiconductor Quantum Dots," Nano Letters 4 (2004): 11-18.
34. Gaponik, N., Radtchenko, I. L., Gerstenberger, M. R., Fedutik, Y. A., Sukhorukov, G. B., and Rogach, A. L. "Labeling of Biocompatible Polymer Microcapsules with Near-Infrared Emitting Nanocrystals," Nano Letters 3 (2003): 369-372.
35. Weissleder, R., Tung, C.-H., Mahmood, U., and Bogdanov, A., Jr. "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes," Nature Biotechnology 17 (1999): 375-378.
36. Green, N. M. "Avidin," Advances in protein chemistry 29 (1975): 85-133.
37. Goldman Ellen, R., Balighian Eric, D., Mattoussi, H., Kuno, M. K., Mauro, J. M., Tran Phan, T., and Anderson George, P. "Avidin: a natural bridge for quantum dot-antibody conjugates," Journal of the American Chemical Society 124 (2002): 6378-82.
38. Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., and Bruchez, M. P. "Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots," Nature Biotechnology 21 (2003): 41-46.
39. Miller, R. T. "Endogenous Biotin Artifact," The Focus: Immunohistochemistry, 2004.
40. Wang, H., and Pevsner, J. "Detection of endogenous biotin in various tissues: novel functions in the hippocampus and implications for its use in avidin-biotin technology," Cell & Tissue Research 296 (1999): 511-516.
41. Lu, C.-S., Kashima, K., Daa, T., Yokoyama, S., Yanagisawa, S., and Nakayama, I. "Immunohistochemical study of the distribution of endogenous biotin and biotin-binding enzymes in ductal structures of salivary gland tumours," Journal of Oral Pathology & Medicine 29 (2000): 445-451.
42. Willingham, M. C. Immunocytochemical Methods and Protocols. Totowa: Humana Press, 1999.
43. Mahadevan, D., and Saldanha, J. W. "The extracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: implications for drug design," Protein Science 8 (1999): 2546-2549.
44. Trowbridge, I. S. "Endocytosis and signals for internalization. [Erratum to document cited in CA115(21):226211z]," Current Opinion in Cell Biology 3 (1991): 1062.
45. Letourneur, F., and Klausner, R. D. "A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains," Cell (Cambridge, MA, United States) 69 (1992): 1143-57.